#United States #Stryker #Portage #Ankle Surgery #Synchfix EVT

Stryker Launches Synchfix™ EVT: A Breakthrough in Ankle Surgery

In a significant advancement for orthopedic surgery, Stryker has unveiled its next-generation flexible syndesmotic fixation device, the Synchfix EVT. Set to be showcased at the 2026 American College of Foot and Ankle Surgeons (ACFAS) Annual Meeting, this innovative device is designed to simplify the surgical process and enhance ankle stabilization for patients affected by syndesmotic injuries.

Addressing Syndesmotic Injuries

Syndesmotic injuries, often related to sports activities and ankle fractures, can have a detrimental impact on a patient's mobility and overall recovery trajectory. Sadly, these injuries pose challenges not only to patients but also to the healthcare professionals treating them. The launch of Synchfix EVT represents a step forward in alleviating such challenges through advanced design and functionality.

Enhanced Surgical Efficiency

According to Adam Jacobs, Vice President and General Manager of Stryker's Foot and Ankle division, the Synchfix EVT embodies Stryker’s commitment to enhancing the surgical experience for foot and ankle specialists. This device builds on the foundation of the existing Synchfix platform, offering design improvements that reduce the complexity of procedures compared to older models.

One of the standout features of the Synchfix EVT is its all-in-one system that integrates suture tensioning handles directly into the implant instrumentation. This integration allows for one-handed surgical deployment, significantly streamlining the process and minimizing the time required for the operation.

User-Centric Design

The ergonomic handle of the Synchfix EVT provides a seamless user experience, while the low-profile titanium medial implant ensures a minimalist design that prioritizes patient comfort. Designed for soft tissue and bone fixation resulting from ankle syndesmosis disruptions, including cases with or without accompanying fractures, this device serves a broad patient demographic.

Notably, the Synchfix EVT is a pioneer in the market, being the first flexible fixation device cleared for use in adolescent patients. This feature not only broadens the treatment scope but also caters specifically to younger individuals facing similar orthopedic challenges.

Recognition for Innovation

The Synchfix EVT's design and utility have not gone unnoticed, as it recently received the prestigious Red Dot Design Award. This accolade highlights the innovative nature of the device and its instrument as instrumental in simplifying syndesmotic fixation along with optimizing surgical efficiency.

Educational Outreach at ACFAS

At the upcoming ACFAS meeting, Stryker will provide live demonstrations that illustrate the functionality and benefits of the Synchfix EVT. Attendees will have the opportunity to observe firsthand how this sterile, single-use, knotless suture-button system enhances stabilization strategies for syndesmotic injuries. This educational outreach emphasizes Stryker’s commitment to equipping surgeons with effective tools to improve patient outcomes.

Stryker: A Leader in Medical Technologies

Stryker is recognized globally as a pioneer in medical technologies, offering groundbreaking products and services across various disciplines including MedSurg, Neurotechnology, and Orthopaedics. With a mission focused on improving healthcare outcomes for patients, Stryker touches the lives of over 150 million individuals annually through collaboration with healthcare practitioners worldwide.

In conclusion, the launch of the Synchfix EVT marks a transformative moment in the realm of ankle surgery, merging innovative design with improved clinical outcomes. It solidifies Stryker’s dedication to advancing patient care while addressing the needs of healthcare professionals everywhere. For more information, visit www.stryker.com.